Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MedBioinformatics provides advanced bioinformatics solutions leveraging AI, NLP, and semantic integration to accelerate drug R&D, support precision medicine initiatives, assess health risks of chemicals, and streamline biomedical research. Their flagship product is DISGENET—the world’s most extensive gene-disease association database—used by over 11,000 users with more than 7,200 bibliographic citations since its launch in 2010. The company does not develop drugs directly but enables faster therapeutic development through its data-driven tools.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MedBioinformatics.